Artículos por temáticas

Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?

Serafini MM, Catanzaro M, Rosini M, Racchi M, Lanni C.

Pharmacol Res. 2017 Oct;124:146-155. doi: 10.1016/j.phrs.2017.08.004. Epub 2017 Aug 12.

The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial

Rijpma A, van der Graaf M, Lansbergen MM, Meulenbroek O, Cetinyurek-Yavuz A, Sijben JW, Heerschap A, Olde Rikkert MGM.

Alzheimers Res Ther. 2017 Jul 26;9(1):51. doi: 10.1186/s13195-017-0286-2.

Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease

Ashok BS, Ajith TA, Sivanesan S.

Clin Exp Pharmacol Physiol. 2017 Mar;44(3):327-334. doi: 10.1111/1440-1681.12717.

Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients

Vakilian A, Razavi-Nasab SM, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, Bahramabadi R, Rezayati M, Yazdanpanah-Ravari A, Bahmaniar F, Bagheri MR, Sheikh Fathollahi M, Asadikaram G, Kazemi Araba

Neuroimmunomodulation. 2017;24(6):310-319. doi: 10.1159/000486597. Epub 2018 Mar 20.

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy

Valis M, Masopust J, Vysata O, Hort J, Dolezal R, Tomek J, Misik J, Kuca K, Karasova JZ.

Neurotox Res. 2017 Jan;31(1):162-168. doi: 10.1007/s12640-016-9672-y. Epub 2016 Oct 7.

Synaptic Plasticity, Dementia and Alzheimer Disease

Skaper SD, Facci L, Zusso M, Giusti P.

CNS Neurol Disord Drug Targets. 2017;16(3):220-233. doi: 10.2174/1871527316666170113120853.

Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data

Yoshida K, Roberts R, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

Am J Geriatr Psychiatry. 2017 Jul;25(7):708-716. doi: 10.1016/j.jagp.2017.01.016. Epub 2017 Jan 30.

Effect of different blood glucose intervention plans on elderly people with type 2 diabetes mellitus combined with dementia

Chen Y, Wang J, Wang LJ, Lin H, Huang PJ.

Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2702-2707.

Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease

Alam J, Blackburn K, Patrick D.

J Prev Alzheimers Dis. 2017;4(4):273-278. doi: 10.14283/jpad.2017.41.

MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease

Reddy PH, Williams J, Smith F, Bhatti JS, Kumar S, Vijayan M, Kandimalla R, Kuruva CS, Wang R, Manczak M, Yin X, Reddy AP.

Prog Mol Biol Transl Sci. 2017;146:127-171. doi: 10.1016/bs.pmbts.2016.12.009. Epub 2017 Feb 2.

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

Kasai T, Kondo M, Ishii R, Tanaka A, Ataka S, Shimada H, Tomiyama T, Mori H, Taylor M, Allsop D, Nakagawa M, Mizuno T, Tokuda T.

PLoS One. 2017 Apr 10;12(4):e0174630. doi: 10.1371/journal.pone.0174630. eCollection 2017.

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players

Gasiorowski K, Brokos B, Leszek J, Tarasov VV, Ashraf GM, Aliev G.

Curr Top Med Chem. 2017;17(12):1429-1437. doi: 10.2174/1568026617666170103161233.

[Efficacy and tolerance of Memantine monotherapy and combination therapy with Reinhartdt And Sea Cucumber Capsule on agitation in moderate to severe Alzheimer disease]

Yu EY, Liao ZL, Tan YF, Qiu YJ, Zhu JP, Chen Y, Lin SS, Wu MH.

Zhonghua Yi Xue Za Zhi. 2017 Jul 18;97(27):2091-2094. doi: 10.3760/cma.j.issn.0376-2491.2017.27.003.

[Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease]

Petit AE, Mangeard H, Chazard E, Puisieux F.

Encephale. 2017 Feb;43(1):21-26. doi: 10.1016/j.encep.2015.03.006. Epub 2016 Mar 30.

Acute cholinergic syndrome in a patient with mild Alzheimer's type dementia who had applied a large number of rivastigmine transdermal patches on her body

Suzuki Y, Kamijo Y, Yoshizawa T, Fujita Y, Usui K, Kishino T.

Clin Toxicol (Phila). 2017 Nov;55(9):1008-1010. doi: 10.1080/15563650.2017.1329536. Epub 2017 Jun 8.